Influx Healthtech IPO is a book building of ₹58.57 crores. The issue is a combination of fresh issue of 50.00 lakh shares aggregating to ₹48.00 crores and offer for sale of 11.00 lakh shares aggregating to ₹10.56 crores.
Newipo.info
Influx Healthtech IPO opens for subscription on June 18, 2025 and closes on June 20, 2025. The allotment for the Influx Healthtech IPO is expected to be finalized on Monday, June 23, 2025. Influx Healthtech IPO will be list on NSE SME with a tentative listing date fixed as Wednesday, June 25, 2025.
Influx Healthtech IPO price band is set at ₹91 to ₹96 per share. The minimum lot size for an application is 1200. The minimum amount of investment required by retail investors is ₹1,09,200. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹1,15,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹2,30,400.
Influx Healthtech IPO Details
| IPO Date | June 18, 2025 to June 20, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | ₹91 to ₹96 per share |
| Lot Size | 1,200 Shares |
| Total Issue Size | 61,00,800 shares (aggregating up to ₹58.57 Cr) |
| Fresh Issue | 50,00,400 shares (aggregating up to ₹48.00 Cr) |
| Offer for Sale | 11,00,400 shares of ₹10 (aggregating up to ₹10.56 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,81,50,000 shares |
| Share Holding Post Issue | 2,31,50,400 shares |
| Market Maker Portion | 3,06,000 shares |
Influx Healthtech IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Isssue |
Influx Healthtech IPO Timeline (Tentative Schedule)
Influx Healthtech IPO opens on June 18, 2025, and closes on June 20, 2025.
| IPO Open Date | Wed, Jun 18, 2025 |
| IPO Close Date | Fri, Jun 20, 2025 |
| Tentative Allotment | Mon, Jun 23, 2025 |
| Initiation of Refunds | Tue, Jun 24, 2025 |
| Credit of Shares to Demat | Tue, Jun 24, 2025 |
| Tentative Listing Date | Wed, Jun 25, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 20, 2025 |
Influx Healthtech IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹1,15,200 |
| Retail (Max) | 1 | 1200 | ₹1,15,200 |
| HNI (Min) | 2 | 2,400 | ₹2,30,400 |
| Lot Size Calculator | |||
Influx Healthtech IPO Promoter Holding
The promoters of the company are Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala and Mr. Abdul Ganee Abdul Rasul Chandniwala.
| Share Holding Pre Issue | 99.85% |
| Share Holding Post Issue | 73.53% |
Company Financials
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 70.30 | 41.10 | 28.30 |
| Revenue | 104.99 | 100.10 | 76.07 |
| Profit After Tax | 13.37 | 11.22 | 7.20 |
| Net Worth | 36.15 | 22.87 | 11.65 |
| Reserves and Surplus | 18.00 | 22.85 | 11.63 |
| Total Borrowing | 0.22 | 0.32 | 0.80 |
For more details, check out the Oswal Pumps’ IPO RHP. You can visit our website at newipo.info for all the latest updates on the current IPO, upcoming IPOs, IPO GMP, today’s IPO GMP, or the IPO Allotment Status. Our reliable website offers a variety of benefits for investors.
About Influx Healthtech Limited
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialized services to clients in multiple industries.
The company has three manufacturing facilities in Thane, Maharashtra, each covering an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.
Product Portfolio:
- Tablets, Capsules, and Powders
- Liquid Orals and Softgels
- Lozenges, Jellies, and Gummies
- Oral Dispersible Films (ODFs)
- Effervescent Tablets and Liquid-Fill Capsules
- Candies and Gym/Sports Supplements
- Skin Care and Body Care Products
- Hair Care and Beard Care Solutions
- Face Masks and Soaps.
- Ayurvedic / Herbal formulations
- Veterinary Feed Supplements
- Homecare solutions
The Company aids Nutraceutical and Cosmetic firms with product development and manufacturing. It offers end-to-end services, including development, production, and regulatory support, enabling clients to focus on formulation and commercialization.
As of June 11, 2025, the company has 163 permanent employees on a payroll basis.
Competitive Strength
- Diversified Product Portfolio
- Diverse Clientele
- Stringent Quality Assurance/Quality Control
- Experienced and Qualified Promoters and Management team.